-
10-22MicroPort NeuroScientific Receives Approval for Its NUMEN™ Silk in the USAWashington, USA, October 21, 2024 — On September 30, MicroPort NeuroTech (Shanghai) Co., Ltd., the subsidiary of MicroPort NeuroScientific received US FDA clearance for NUMEN™ Silk Coil Embolization System (NUMEN™ Silk), marking its second international market clearance following its initial clearance in the US.
-
09-06Announcement:MicroPort NeuroTech Officially Changes Its Name to MicroPort NeuroScientificWe are pleased to announce that our company has officially been renamed to MicroPort NeuroScientific Corporation.
-
07-22MicroPort® NeuroTech™ Completes World's First Application of PCAR Intervention SystemShanghai, China — Recently, the Percutaneous Neuroprotection for Carotid Artery Remodelling (PCAR) (PCAR) Intervention System, jointly developed by MicroPort® NeuroTech™ in collaboration with Prof. Bo Yu's team at Fudan University Pudong Medical Center, achieved a global milestone with the completion of the world's first PCAR procedure at the center. This successful intervention rescued a patient suffering from severe carotid artery stenosis. The PCAR represents an evolution from Transcarotid Artery Revascularization (TCAR), further advancing minimally invasive techniques and simplifying operations.